We welcome an exciting step forward in our campaign to expand the availability of life-changing diabetes technology, as new proposals for wider access to Flash and continuous glucose monitoring (CGM) are released.
NICE draft guidelines propose wider use of Flash and CGM technology
Today the National Institute for Health and Care Excellence (NICE) has published draft guidelines which recommend that Flash glucose monitoring or continuous glucose monitoring should be available for all adults with type 1 diabetes.
Guideline proposals have been released about glucose monitoring for adults with type 1 diabetes and type 2 diabetes and for children and young people with either type 1 or type 2 diabetes.
The draft guideline also recommends all children living with type 1 diabetes use continuous glucose monitoring too.
This is a hugely welcome step towards more people having access to this life changing technology – which we know improves blood sugar control and makes life easier for people with type 1 diabetes and their parents and carers.
Access to Flash for people with type 2 diabetes
The draft NICE proposals also recommend access to Flash for people with type 2 diabetes who use insulin intensive therapy (4 or more injections a day) and experience regular hypoglycaemia or severe hypoglycaemia, amongst other criteria.
We’re pleased to see NICE recognising that more people living with type 2 diabetes can benefit from Flash – something we’ve highlighted consistently, especially in our Cheque for Tech campaign last year and this year's Diabetes is Serious campaign.
Pushing for more access to CGM and Flash
At the moment, NICE only recommends access to CGM in very limited circumstances and the guidelines don't mention Flash at all.
We've been involved every step of the way in this guideline update process, pushing for better access to this important technology. We’re thrilled to see NICE listen to us, and others, who have been calling for them to recommend wider Flash and CGM use.
While health care professionals don't have to follow NICE guidelines, such as those proposed today, they are influential. Health care professionals frequently use them to inform the decisions they make for their patients' care.
We'll be responding to the consultation on this draft guideline and welcome this big step forward. We expect the final guidance to be published in March 2022.
We look forward to continuing to work with NICE, the NHS and local Integrated Care Systems (the NHS partnerships created to join up health and care services available to patients locally).
We sincerely hope that, when the final guidelines are published, local leaders within healthcare systems will do all they can to make them a reality.